OneSkin, the pioneering skin longevity brand, powered by biotech and grounded in science, is proud to announce a $20 million Series A investment from growth equity firm Prelude Growth Partners. 

Founded by a team of female PhD scientists, OneSkin is the first brand to focus exclusively on extending skinspan — the period during which skin remains healthy and functional, by using rigorous scientific research to target the underlying mechanisms of aging, not just surface appearance. 

The investment, completed last month, reflects Prelude Growth’s strong conviction in OneSkin’s mission and potential, and marks a significant milestone in the brand’s next chapter of growth.

Carolina Reis Oliveira, PhD, Co-Founder and CEO of OneSkin, said, 

“We’re incredibly proud to welcome Prelude Growth Partners to the OneSkin family. Their team’s expertise in building modern consumer brands, and their enthusiasm for our science-driven approach made this a natural fit. We weren’t looking for new capital — but their passion and belief in our vision made this an opportunity to expand our resources and work alongside people we deeply admire.”

OneSkin’s approach centers around longevity science, particularly targeting senescent cells—the aging cells that accumulate in skin over time and contribute to inflammation, collagen breakdown, and visible signs of aging. 

OneSkin’s proprietary peptide, OS-01, is designed to reduce the burden of senescent cells, aiming to create skin that looks and behaves like younger skin.

Alicia Sontag, Co-Founder and Managing Partner of Prelude Growth, commented,

“OneSkin’s cutting-edge science, novel proprietary technology, leadership in skin longevity, and compelling brand are truly unique in the category. We are extremely proud to have the opportunity to partner with Carolina, Alessandra, and the team at OneSkin to support them in creating an iconic, powerhouse brand of the future.”

Prelude Growth Partners proactively approached the brand with a desire to invest, and OneSkin leveraged the opportunity to replace an early seed stage investor with a partner who could best support them in this next stage of growth. 

This strategic investment underscores Prelude Growth’s belief in the long-term potential of skin longevity as a category and in OneSkin’s leadership at the forefront of this movement.